Karachi, AGP Limited, a leading pharmaceutical company, has announced that a meeting of its Board of Directors is scheduled to take place on September 28, 2023. The meeting, which will be held in Karachi, will also offer a video facility for remote participation. The primary agenda for the meeting is to discuss matters other than financial results.

In compliance with Clause 5.6.4 of the PSX Regulation, AGP Limited has officially declared a "Closed Period" starting from September 27, 2023, extending until September 28, 2023. During this Closed Period, none of the Directors, CEOs, or Executives of the company are permitted to engage in any direct or indirect dealings involving the shares of AGP Limited.

The Closed Period is a standard practice in financial markets, designed to maintain transparency and prevent insider trading activities. During this time frame, individuals with access to privileged information about the company are prohibited from buying or selling its shares, ensuring a level playing field for all investors.

AGP Limited has a longstanding commitment to adhering to regulatory standards and promoting fair practices in the industry. The Board of Directors' meeting on September 28, 2023, is expected to facilitate discussions on strategic initiatives and decisions that will contribute to the company's continued growth and success.

Investors and stakeholders will eagerly await the outcomes of this meeting, as AGP Limited continues to be a key player in the pharmaceutical sector, both in Pakistan and internationally. The company's dedication to transparency and ethical conduct remains a hallmark of its corporate governance.